{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:26:41Z","timestamp":1788323201910,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jphs.2024.02.012","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T02:29:27Z","timestamp":1708741767000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells"],"prefix":"10.1016","volume":"154","author":[{"given":"Xingming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kou","family":"Nishikubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Ohgaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Okanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-286X","authenticated-orcid":false,"given":"Yoshikatsu","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.jphs.2024.02.012_bib1","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)","volume":"273","author":"Kanai","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jphs.2024.02.012_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","article-title":"Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines","volume":"1514","author":"Yanagida","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jphs.2024.02.012_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jphs.2024.02.012_bib4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","article-title":"Amino acid transporters revisited: new views in health and disease","volume":"43","author":"Kandasamy","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jphs.2024.02.012_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.564809","article-title":"Review of the correlation of LAT1 with diseases: mechanism and treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Chem"},{"issue":"5","key":"10.1016\/j.jphs.2024.02.012_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40291-020-00470-x","article-title":"Prognostic value of L-type amino acid transporter 1 (LAT1) in various cancers: a meta-analysis","volume":"24","author":"Zhang","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","article-title":"L-type amino acid transporter 1 inhibitors inhibit tumor cell growth","volume":"101","author":"Oda","year":"2010","journal-title":"Cancer Sci"},{"issue":"4_suppl l","key":"10.1016\/j.jphs.2024.02.012_bib8","article-title":"Nanvuranlat, an L-type amino acid transporter (LAT1) inhibitor for patients with pretreated advanced refractory biliary tract cancer (BTC): primary endpoint results of a randomized, double-blind, placebo-controlled phase 2 study","volume":"41","author":"Furuse","year":"2023","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jphs.2024.02.012_bib9","doi-asserted-by":"crossref","first-page":"14484","DOI":"10.1074\/jbc.273.23.14484","article-title":"Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism","volume":"273","author":"Hara","year":"1998","journal-title":"J Biol Chem"},{"issue":"6268","key":"10.1016\/j.jphs.2024.02.012_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"Wolfson","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jphs.2024.02.012_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.jphs.2024.02.012_bib12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.012_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3945\/an.112.002113","article-title":"Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism","volume":"3","author":"Baird","year":"2012","journal-title":"Adv Nutr"},{"issue":"9","key":"10.1016\/j.jphs.2024.02.012_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tem.2009.05.008","article-title":"ATF4-dependent transcription mediates signaling of amino acid limitation","volume":"20","author":"Kilberg","year":"2009","journal-title":"Trends Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12935-023-02957-z","article-title":"Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells","volume":"23","author":"Nishikubo","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"20","key":"10.1016\/j.jphs.2024.02.012_bib16","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1111\/jcmm.17553","article-title":"Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells","volume":"26","author":"Nishikubo","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.jphs.2024.02.012_bib18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ncb1333","article-title":"A role for the P-body component GW182 in microRNA function","volume":"7","author":"Liu","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"12","key":"10.1016\/j.jphs.2024.02.012_bib19","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nsmb.2413","article-title":"A direct interaction between DCP1 and XRN1 couples mRNA decapping to 5\u2019 exonucleolytic degradation","volume":"19","author":"Braun","year":"2012","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10.1016\/j.jphs.2024.02.012_bib20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nsmb.1709","article-title":"Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps","volume":"16","author":"Chen","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"6128","key":"10.1016\/j.jphs.2024.02.012_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1126\/science.1231197","article-title":"Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation","volume":"340","author":"Meijer","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molcel.2014.09.004","article-title":"MicroRNAs block assembly of eIF4F translation initiation complex in Drosophila","volume":"56","author":"Fukaya","year":"2014","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molcel.2014.09.005","article-title":"MicroRNAs trigger dissociation of eIF4AI and eIF4AII from target mRNAs in humans","volume":"56","author":"Fukao","year":"2014","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12935-015-0185-1","article-title":"MicroRNA (miRNA) in cancer","volume":"15","author":"Reddy","year":"2015","journal-title":"Cancer Cell Int"},{"issue":"14","key":"10.1016\/j.jphs.2024.02.012_bib25","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in Cancer","volume":"16","author":"He","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jphs.2024.02.012_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biopha.2015.04.001","article-title":"MicroRNA-126 inhibits cell proliferation in gastric cancer by targeting LAT-1","volume":"72","author":"Wang","year":"2015","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.jphs.2024.02.012_bib27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.febslet.2011.03.039","article-title":"miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5","volume":"585","author":"Miko","year":"2011","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.jphs.2024.02.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130496","article-title":"miR-126-3p inhibits thyroid cancer cell growth and metastasis, and is associated with aggressive thyroid cancer","volume":"10","author":"Xiong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2024.02.012_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1025594","article-title":"Genome-wide association studies identify miRNA-194 as a prognostic biomarker for gastrointestinal cancer by targeting ATP6V1F, PPP1R14B, BTF3L4 and SLC7A5","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1471-2407-13-482","article-title":"Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer","volume":"13","author":"Kaira","year":"2013","journal-title":"BMC Cancer"},{"issue":"1.2","key":"10.1016\/j.jphs.2024.02.012_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2152\/jmi.70.160","article-title":"Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma","volume":"70","author":"Selenge","year":"2023","journal-title":"J Med Invest"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40170-022-00295-8","article-title":"Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of L-type amino acid transporter 1","volume":"10","author":"Okanishi","year":"2022","journal-title":"Cancer Metabol"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.012_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317694545","article-title":"Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment","volume":"39","author":"Yothaisong","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jphs.2024.02.012_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"issue":"D1","key":"10.1016\/j.jphs.2024.02.012_bib35","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jphs.2024.02.012_bib36","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkt393","article-title":"DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows","volume":"41","author":"Paraskevopoulou","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"10.1016\/j.jphs.2024.02.012_bib37","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1093\/nar\/gks901","article-title":"MiRmap: comprehensive prediction of microRNA target repression strength","volume":"40","author":"Vejnar","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.jphs.2024.02.012_bib38","doi-asserted-by":"crossref","first-page":"D812","DOI":"10.1093\/nar\/gkw1079","article-title":"dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers","volume":"45","author":"Yang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"6136","key":"10.1016\/j.jphs.2024.02.012_bib39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.1232044","article-title":"A tumor suppressor complex with GAP activity for the rag GTPases that signal amino acid sufficiency to mTORC1","volume":"340","author":"Bar-Peled","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2014.09.014","article-title":"The sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1","volume":"9","author":"Chantranupong","year":"2014","journal-title":"Cell Rep"},{"issue":"6364","key":"10.1016\/j.jphs.2024.02.012_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aao3265","article-title":"SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway","volume":"358","author":"Gu","year":"2017","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jphs.2024.02.012_bib42","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1074\/jbc.AC119.011578","article-title":"Glutamine and asparagine activate mTORC1 independently of Rag GTPases","volume":"295","author":"Meng","year":"2020","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.jphs.2024.02.012_bib43","doi-asserted-by":"crossref","first-page":"22414","DOI":"10.1074\/jbc.M116.732511","article-title":"Amino acids regulate mTORC1 by an obligate two-step mechanism","volume":"291","author":"Dyachok","year":"2016","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.012_bib44","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3892\/or.2012.1878","article-title":"c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells","volume":"28","author":"Hayashi","year":"2012","journal-title":"Oncol Rep"},{"issue":"37","key":"10.1016\/j.jphs.2024.02.012_bib45","doi-asserted-by":"crossref","first-page":"E7697","DOI":"10.1073\/pnas.1710366114","article-title":"Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC","volume":"114","author":"Satoh","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"JUN","key":"10.1016\/j.jphs.2024.02.012_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fonc.2018.00214","article-title":"Hypoxia-inducible factor 2-dependent pathways driving von hippel-lindau-deficient renal cancer","volume":"8","author":"Mel\u00e9ndez-Rodr\u00edguez","year":"2018","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.jphs.2024.02.012_bib47","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1158\/0008-5472.CAN-11-1821","article-title":"Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.jphs.2024.02.012_bib48","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.celrep.2019.05.039","article-title":"The RNA-binding protein YBX3 controls amino acid levels by regulating SLC mRNA abundance","volume":"27","author":"Cooke","year":"2019","journal-title":"Cell Rep"},{"issue":"7755","key":"10.1016\/j.jphs.2024.02.012_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-019-1126-2","article-title":"LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer","volume":"569","author":"Saito","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jphs.2024.02.012_bib50","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.21873\/anticanres.16634","article-title":"miR-122-5p restrains pancreatic cancer cell growth and causes apoptosis by negatively regulating ASCT2","volume":"43","author":"Ren","year":"2023","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.jphs.2024.02.012_bib51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.semcancer.2005.04.005","article-title":"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?","volume":"15","author":"Fuchs","year":"2005","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.012_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jphs.2024.02.012_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107822","article-title":"miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer","volume":"97","author":"Wang","year":"2021","journal-title":"Int Immunopharm"},{"issue":"1","key":"10.1016\/j.jphs.2024.02.012_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-017-0737-1","article-title":"Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122","volume":"16","author":"Su","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jphs.2024.02.012_bib55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.biopha.2016.03.026","article-title":"MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer","volume":"80","author":"Zhang","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.jphs.2024.02.012_bib56","article-title":"MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.jphs.2024.02.012_bib57","first-page":"4925","article-title":"MiR-122 inhibits cell proliferation and induces apoptosis by targeting runt-related transcription factors 2 in human glioma","volume":"22","author":"Ding","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.jphs.2024.02.012_bib58","doi-asserted-by":"crossref","first-page":"15615","DOI":"10.1007\/s13277-015-4308-z","article-title":"miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma","volume":"37","author":"Lu","year":"2016","journal-title":"Tumor Biol"},{"issue":"3","key":"10.1016\/j.jphs.2024.02.012_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.jphs.2024.02.012_bib60","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:04:24Z","timestamp":1761163464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861324000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1347861324000239"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.02.012","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}